Transient Expression Kit

Apply for trial

Powered by the Fluorescent Site-specific Integration Cell line Development Platform (AlfaCell), Alfaexpress transient expression kit offers a one-stop protein expression solution for CHO-K1 cells. It achieves yields significantly higher than commercial transient expression kit, using the same cell line for both transient and stable development. This ensures seamless quality consistency from early research to CMC, bridging the gap to large-scale manufacturing.

Transient Expression in CHO-K1 Cell Line

The Alfaexpress transient expression kit leverages site-specific integration technology for rapid transient protein expression in CHO-K1 cells. Monoclonal antibody yields reach 300-1,000 mg/L by day 14—far exceeding commercial kit performance—while maintaining high cell viability. Ideal for fast protein sample generation and early evaluation of expression, post-translational modification, and stability.

One Cell Line for Both Transient and Stable Expression

The Alfaexpress transient expression kit enables seamless use of the same CHO-K1 cell line for both transient and stable expression, ensuring consistent product quality. This bridges early research and CMC, reducing efficacy gaps and lowering development risk.

Product Information

Name CHO Cell Culture Medium Expression Medium Feed AC Enhancer Trans A Trans B Trans G GBB-lp02 GBB-p10
Product Passage & Expansion Medium Transfection & Expression Medium Feed Medium Expression Enhancer Transfection Reagent Positive Control Plasmid Empty Vector Plasmid
Product Code NF3370 EM3302 EM3302 Feed AC Enhancer 01 Trans A01 Trans B01 Trans G01 GBB-Ip02 GBB-p10
Quantity 1000 ml 1000 ml 200 ml 2 ml*2 1 ml*2 1.75 ml*4 0.3 ml 0.12 ml 25 μl

Case Study

  • Superior Titers

    Across six tested mAbs, Alfaexpress consistently outperforms leading commercial kits, with yields reaching up to ~900 mg/L. This ensures a high-yield foundation for rapid early-stage sample preparation.
  • Enhanced Cell Viability

    Maintains higher cell viability throughout the 14-day culture period. Its superior robustness in later stages provides significant stability compared to standard commercial solutions.
  • Cell Viability

    Alfaexpress delivered a faster and higher titer increase for mAb-6, reaching nearly 1,000 mg/L by day 14.

  • Seamless CMC Transition

    By utilizing the same CHO-K1 cell line for both transient and stable expression, Alfaexpress ensures consistent product quality (e.g., 61.8% main peak), effectively bridging the gap between discovery and CMC.

    Schedule a Meeting

    I agree to the privacy policy.

    Submit
    Global Bioprocessing Made Simpler and More Efficient